Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continentsEmanuele Di Angelantonio, Frank B. Hu, Zhengming Chen et al.|The Lancet|2016Cited by 2.8k
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trialsSøren Lund Kristensen, John J.V. McMurray, Rasmus Rørth et al.|The Lancet Diabetes & Endocrinology|2019Cited by 1.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetesNikolaus Marx, Konstantinos C. Koskinas, Massimo Federici et al.|European Heart Journal|2023Cited by 1.4k
Definition and diagnostic criteria of clinical obesityFrancesco Rubino, An Pan, Harvey J. Grill et al.|The Lancet Diabetes & Endocrinology|2025Cited by 1.3k